Low-Molecular-Weight Heparin and Other Antithrombotic Agents in the Setting of a Primarily Medical Treatment of Unstable Coronary Artery Disease

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 122-127

Karger

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin as a Bridge to Timely Revascularization in Unstable Coronary Artery Disease – an Update of the Fragmin during Instability in Coronary Artery Disease II Trial

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 108-113

Karger

Access to resources Recommend Favorite

Low-Molecular-Weight Heparins in Acute Unstable Coronary Artery Disease – An Update

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 1, 2004-11 ,pp. : 72-75

Karger

Access to resources Recommend Favorite

Antithrombotic Therapy in Coronary Ischaemia: The Expanding Role of Low-Molecular-Weight Heparin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 35-42

Karger

Access to resources Recommend Favorite

Antithrombotic drugs in acutely ill medical patients: review and meta-analysis of interventional trials with low-molecular-weight heparin and fondaparinux

By Loffredo Lorenzo   Perri Ludovica   Catasca Elisa   Del Ben Maria   Angelico Francesco   Violi Francesco  

Clinical Practice, Vol. 10, Iss. 5, 2013-09 ,pp. : 615-627

Future Medicine

Access to resources Recommend Favorite